Global and Regional Apheresis
Global and Regional Apheresis

Apheresis Comprehensive Study by Type (Apheresis Devices, Apheresis Disposables), Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Other Applications), Technology (Centrifugation, Membrane Separation), Procedure (Automated blood collection (Donor Apheresis), Therapeutic Apheresis) Players and Region - Global Market Outlook to 2026

Apheresis Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 247 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Apheresis Market Overview:
Apheresis is a medical technology in which the blood of a person is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. The increasing demand for blood components and growing concerns regarding blood safety across the globe, rising prevalence of various blood disorders, increasing number of surgical procedures and emergency care cases in hospitals around the world are driving market growth. Extending reach of apheresis in the untapped paediatric segment and growth in emerging markets due to increasing investments presents significant growth opportunities for players in this market. However, high costs of apheresis machines & procedures and scarcity of qualified donors are the major restraining factors for this market.

Growth Drivers
  • Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases
  • Rising Demand for Blood Components and Growing Concerns Regarding Blood Safety
  • Increase in the Number of Complex Surgical Procedures

Market Trends
  • Increasing Demand for Source Plasma From Biopharmaceutical Companies
  • Favourable Reimbursement for Apheresis Procedures

Roadblocks
  • High Cost of Apheresis Devices & Therapeutic Apheresis Procedures and Installation of Apheresis Devices Through Rental Model
  • Fewer Blood Donations Using Apheresis Due to Lack of Awareness
  • Stringent Donor Recruitment Criteria

Opportunities
  • Apheresis for Leukemia and Pediatric Patients
  • Emerging Economies With Increasing Investments From Government Bodies and Leading Players

Challenges
  • Recruitment of Voluntary Non-Remunerated Donors
  • Safety of Blood Transfusion in Developing Countries


Competitive Landscape:
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.
Some of the key players profiled in the report are Terumo BCT, Inc. (United States), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (United States), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (United States), Cerus Corporation (United States), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan) and Nikkiso Co., Ltd. (Japan). Analyst at AMA Research see United States and Japanese Players to retain maximum share of Global Apheresis market by 2026. Considering Market by Technology, the sub-segment i.e. Centrifugation will boost the Apheresis market. Considering Market by Procedure, the sub-segment i.e. Automated blood collection (Donor Apheresis) will boost the Apheresis market.

Latest Market Insights:
In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.

In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Apheresis market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Apheresis market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Apheresis Procedure Giver, Apheresis Treatment Providers, Research and Development Institutes, Potential Investors, Hospitals, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Apheresis Devices
  • Apheresis Disposables
By Application
  • Plasmapheresis
  • Plateletpheresis
  • Erythrocytapheresis
  • Leukapheresis
  • Other Applications
By Technology
  • Centrifugation
  • Membrane Separation

By Procedure
  • Automated blood collection (Donor Apheresis)
  • Therapeutic Apheresis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases
      • 3.2.2. Rising Demand for Blood Components and Growing Concerns Regarding Blood Safety
      • 3.2.3. Increase in the Number of Complex Surgical Procedures
    • 3.3. Market Challenges
      • 3.3.1. Recruitment of Voluntary Non-Remunerated Donors
      • 3.3.2. Safety of Blood Transfusion in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Source Plasma From Biopharmaceutical Companies
      • 3.4.2. Favourable Reimbursement for Apheresis Procedures
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Apheresis, by Type, Application, Technology, Procedure and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Apheresis (Value)
      • 5.2.1. Global Apheresis by: Type (Value)
        • 5.2.1.1. Apheresis Devices
        • 5.2.1.2. Apheresis Disposables
      • 5.2.2. Global Apheresis by: Application (Value)
        • 5.2.2.1. Plasmapheresis
        • 5.2.2.2. Plateletpheresis
        • 5.2.2.3. Erythrocytapheresis
        • 5.2.2.4. Leukapheresis
        • 5.2.2.5. Other Applications
      • 5.2.3. Global Apheresis by: Technology (Value)
        • 5.2.3.1. Centrifugation
        • 5.2.3.2. Membrane Separation
      • 5.2.4. Global Apheresis by: Procedure (Value)
        • 5.2.4.1. Automated blood collection (Donor Apheresis)
        • 5.2.4.2. Therapeutic Apheresis
      • 5.2.5. Global Apheresis Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Apheresis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Terumo BCT, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Fresenius SE & Co. KGaA (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Haemonetics Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Asahi Kasei Medical Co. Ltd. (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. B. Braun Melsungen AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Baxter International Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cerus Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Kaneka Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Kawasumi Laboratories, Inc. (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nikkiso Co., Ltd. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Apheresis Sale, by Type, Application, Technology, Procedure and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Apheresis (Value)
      • 7.2.1. Global Apheresis by: Type (Value)
        • 7.2.1.1. Apheresis Devices
        • 7.2.1.2. Apheresis Disposables
      • 7.2.2. Global Apheresis by: Application (Value)
        • 7.2.2.1. Plasmapheresis
        • 7.2.2.2. Plateletpheresis
        • 7.2.2.3. Erythrocytapheresis
        • 7.2.2.4. Leukapheresis
        • 7.2.2.5. Other Applications
      • 7.2.3. Global Apheresis by: Technology (Value)
        • 7.2.3.1. Centrifugation
        • 7.2.3.2. Membrane Separation
      • 7.2.4. Global Apheresis by: Procedure (Value)
        • 7.2.4.1. Automated blood collection (Donor Apheresis)
        • 7.2.4.2. Therapeutic Apheresis
      • 7.2.5. Global Apheresis Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Apheresis: by Type(USD Million)
  • Table 2. Apheresis Apheresis Devices , by Region USD Million (2015-2020)
  • Table 3. Apheresis Apheresis Disposables , by Region USD Million (2015-2020)
  • Table 4. Apheresis: by Application(USD Million)
  • Table 5. Apheresis Plasmapheresis , by Region USD Million (2015-2020)
  • Table 6. Apheresis Plateletpheresis , by Region USD Million (2015-2020)
  • Table 7. Apheresis Erythrocytapheresis , by Region USD Million (2015-2020)
  • Table 8. Apheresis Leukapheresis , by Region USD Million (2015-2020)
  • Table 9. Apheresis Other Applications , by Region USD Million (2015-2020)
  • Table 10. Apheresis: by Technology(USD Million)
  • Table 11. Apheresis Centrifugation , by Region USD Million (2015-2020)
  • Table 12. Apheresis Membrane Separation , by Region USD Million (2015-2020)
  • Table 13. Apheresis: by Procedure(USD Million)
  • Table 14. Apheresis Automated blood collection (Donor Apheresis) , by Region USD Million (2015-2020)
  • Table 15. Apheresis Therapeutic Apheresis , by Region USD Million (2015-2020)
  • Table 16. South America Apheresis, by Country USD Million (2015-2020)
  • Table 17. South America Apheresis, by Type USD Million (2015-2020)
  • Table 18. South America Apheresis, by Application USD Million (2015-2020)
  • Table 19. South America Apheresis, by Technology USD Million (2015-2020)
  • Table 20. South America Apheresis, by Procedure USD Million (2015-2020)
  • Table 21. Brazil Apheresis, by Type USD Million (2015-2020)
  • Table 22. Brazil Apheresis, by Application USD Million (2015-2020)
  • Table 23. Brazil Apheresis, by Technology USD Million (2015-2020)
  • Table 24. Brazil Apheresis, by Procedure USD Million (2015-2020)
  • Table 25. Argentina Apheresis, by Type USD Million (2015-2020)
  • Table 26. Argentina Apheresis, by Application USD Million (2015-2020)
  • Table 27. Argentina Apheresis, by Technology USD Million (2015-2020)
  • Table 28. Argentina Apheresis, by Procedure USD Million (2015-2020)
  • Table 29. Rest of South America Apheresis, by Type USD Million (2015-2020)
  • Table 30. Rest of South America Apheresis, by Application USD Million (2015-2020)
  • Table 31. Rest of South America Apheresis, by Technology USD Million (2015-2020)
  • Table 32. Rest of South America Apheresis, by Procedure USD Million (2015-2020)
  • Table 33. Asia Pacific Apheresis, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Apheresis, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Apheresis, by Application USD Million (2015-2020)
  • Table 36. Asia Pacific Apheresis, by Technology USD Million (2015-2020)
  • Table 37. Asia Pacific Apheresis, by Procedure USD Million (2015-2020)
  • Table 38. China Apheresis, by Type USD Million (2015-2020)
  • Table 39. China Apheresis, by Application USD Million (2015-2020)
  • Table 40. China Apheresis, by Technology USD Million (2015-2020)
  • Table 41. China Apheresis, by Procedure USD Million (2015-2020)
  • Table 42. Japan Apheresis, by Type USD Million (2015-2020)
  • Table 43. Japan Apheresis, by Application USD Million (2015-2020)
  • Table 44. Japan Apheresis, by Technology USD Million (2015-2020)
  • Table 45. Japan Apheresis, by Procedure USD Million (2015-2020)
  • Table 46. India Apheresis, by Type USD Million (2015-2020)
  • Table 47. India Apheresis, by Application USD Million (2015-2020)
  • Table 48. India Apheresis, by Technology USD Million (2015-2020)
  • Table 49. India Apheresis, by Procedure USD Million (2015-2020)
  • Table 50. South Korea Apheresis, by Type USD Million (2015-2020)
  • Table 51. South Korea Apheresis, by Application USD Million (2015-2020)
  • Table 52. South Korea Apheresis, by Technology USD Million (2015-2020)
  • Table 53. South Korea Apheresis, by Procedure USD Million (2015-2020)
  • Table 54. Taiwan Apheresis, by Type USD Million (2015-2020)
  • Table 55. Taiwan Apheresis, by Application USD Million (2015-2020)
  • Table 56. Taiwan Apheresis, by Technology USD Million (2015-2020)
  • Table 57. Taiwan Apheresis, by Procedure USD Million (2015-2020)
  • Table 58. Australia Apheresis, by Type USD Million (2015-2020)
  • Table 59. Australia Apheresis, by Application USD Million (2015-2020)
  • Table 60. Australia Apheresis, by Technology USD Million (2015-2020)
  • Table 61. Australia Apheresis, by Procedure USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Apheresis, by Type USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Apheresis, by Application USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Apheresis, by Technology USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Apheresis, by Procedure USD Million (2015-2020)
  • Table 66. Europe Apheresis, by Country USD Million (2015-2020)
  • Table 67. Europe Apheresis, by Type USD Million (2015-2020)
  • Table 68. Europe Apheresis, by Application USD Million (2015-2020)
  • Table 69. Europe Apheresis, by Technology USD Million (2015-2020)
  • Table 70. Europe Apheresis, by Procedure USD Million (2015-2020)
  • Table 71. Germany Apheresis, by Type USD Million (2015-2020)
  • Table 72. Germany Apheresis, by Application USD Million (2015-2020)
  • Table 73. Germany Apheresis, by Technology USD Million (2015-2020)
  • Table 74. Germany Apheresis, by Procedure USD Million (2015-2020)
  • Table 75. France Apheresis, by Type USD Million (2015-2020)
  • Table 76. France Apheresis, by Application USD Million (2015-2020)
  • Table 77. France Apheresis, by Technology USD Million (2015-2020)
  • Table 78. France Apheresis, by Procedure USD Million (2015-2020)
  • Table 79. Italy Apheresis, by Type USD Million (2015-2020)
  • Table 80. Italy Apheresis, by Application USD Million (2015-2020)
  • Table 81. Italy Apheresis, by Technology USD Million (2015-2020)
  • Table 82. Italy Apheresis, by Procedure USD Million (2015-2020)
  • Table 83. United Kingdom Apheresis, by Type USD Million (2015-2020)
  • Table 84. United Kingdom Apheresis, by Application USD Million (2015-2020)
  • Table 85. United Kingdom Apheresis, by Technology USD Million (2015-2020)
  • Table 86. United Kingdom Apheresis, by Procedure USD Million (2015-2020)
  • Table 87. Netherlands Apheresis, by Type USD Million (2015-2020)
  • Table 88. Netherlands Apheresis, by Application USD Million (2015-2020)
  • Table 89. Netherlands Apheresis, by Technology USD Million (2015-2020)
  • Table 90. Netherlands Apheresis, by Procedure USD Million (2015-2020)
  • Table 91. Rest of Europe Apheresis, by Type USD Million (2015-2020)
  • Table 92. Rest of Europe Apheresis, by Application USD Million (2015-2020)
  • Table 93. Rest of Europe Apheresis, by Technology USD Million (2015-2020)
  • Table 94. Rest of Europe Apheresis, by Procedure USD Million (2015-2020)
  • Table 95. MEA Apheresis, by Country USD Million (2015-2020)
  • Table 96. MEA Apheresis, by Type USD Million (2015-2020)
  • Table 97. MEA Apheresis, by Application USD Million (2015-2020)
  • Table 98. MEA Apheresis, by Technology USD Million (2015-2020)
  • Table 99. MEA Apheresis, by Procedure USD Million (2015-2020)
  • Table 100. Middle East Apheresis, by Type USD Million (2015-2020)
  • Table 101. Middle East Apheresis, by Application USD Million (2015-2020)
  • Table 102. Middle East Apheresis, by Technology USD Million (2015-2020)
  • Table 103. Middle East Apheresis, by Procedure USD Million (2015-2020)
  • Table 104. Africa Apheresis, by Type USD Million (2015-2020)
  • Table 105. Africa Apheresis, by Application USD Million (2015-2020)
  • Table 106. Africa Apheresis, by Technology USD Million (2015-2020)
  • Table 107. Africa Apheresis, by Procedure USD Million (2015-2020)
  • Table 108. North America Apheresis, by Country USD Million (2015-2020)
  • Table 109. North America Apheresis, by Type USD Million (2015-2020)
  • Table 110. North America Apheresis, by Application USD Million (2015-2020)
  • Table 111. North America Apheresis, by Technology USD Million (2015-2020)
  • Table 112. North America Apheresis, by Procedure USD Million (2015-2020)
  • Table 113. United States Apheresis, by Type USD Million (2015-2020)
  • Table 114. United States Apheresis, by Application USD Million (2015-2020)
  • Table 115. United States Apheresis, by Technology USD Million (2015-2020)
  • Table 116. United States Apheresis, by Procedure USD Million (2015-2020)
  • Table 117. Canada Apheresis, by Type USD Million (2015-2020)
  • Table 118. Canada Apheresis, by Application USD Million (2015-2020)
  • Table 119. Canada Apheresis, by Technology USD Million (2015-2020)
  • Table 120. Canada Apheresis, by Procedure USD Million (2015-2020)
  • Table 121. Mexico Apheresis, by Type USD Million (2015-2020)
  • Table 122. Mexico Apheresis, by Application USD Million (2015-2020)
  • Table 123. Mexico Apheresis, by Technology USD Million (2015-2020)
  • Table 124. Mexico Apheresis, by Procedure USD Million (2015-2020)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Apheresis: by Type(USD Million)
  • Table 136. Apheresis Apheresis Devices , by Region USD Million (2021-2026)
  • Table 137. Apheresis Apheresis Disposables , by Region USD Million (2021-2026)
  • Table 138. Apheresis: by Application(USD Million)
  • Table 139. Apheresis Plasmapheresis , by Region USD Million (2021-2026)
  • Table 140. Apheresis Plateletpheresis , by Region USD Million (2021-2026)
  • Table 141. Apheresis Erythrocytapheresis , by Region USD Million (2021-2026)
  • Table 142. Apheresis Leukapheresis , by Region USD Million (2021-2026)
  • Table 143. Apheresis Other Applications , by Region USD Million (2021-2026)
  • Table 144. Apheresis: by Technology(USD Million)
  • Table 145. Apheresis Centrifugation , by Region USD Million (2021-2026)
  • Table 146. Apheresis Membrane Separation , by Region USD Million (2021-2026)
  • Table 147. Apheresis: by Procedure(USD Million)
  • Table 148. Apheresis Automated blood collection (Donor Apheresis) , by Region USD Million (2021-2026)
  • Table 149. Apheresis Therapeutic Apheresis , by Region USD Million (2021-2026)
  • Table 150. South America Apheresis, by Country USD Million (2021-2026)
  • Table 151. South America Apheresis, by Type USD Million (2021-2026)
  • Table 152. South America Apheresis, by Application USD Million (2021-2026)
  • Table 153. South America Apheresis, by Technology USD Million (2021-2026)
  • Table 154. South America Apheresis, by Procedure USD Million (2021-2026)
  • Table 155. Brazil Apheresis, by Type USD Million (2021-2026)
  • Table 156. Brazil Apheresis, by Application USD Million (2021-2026)
  • Table 157. Brazil Apheresis, by Technology USD Million (2021-2026)
  • Table 158. Brazil Apheresis, by Procedure USD Million (2021-2026)
  • Table 159. Argentina Apheresis, by Type USD Million (2021-2026)
  • Table 160. Argentina Apheresis, by Application USD Million (2021-2026)
  • Table 161. Argentina Apheresis, by Technology USD Million (2021-2026)
  • Table 162. Argentina Apheresis, by Procedure USD Million (2021-2026)
  • Table 163. Rest of South America Apheresis, by Type USD Million (2021-2026)
  • Table 164. Rest of South America Apheresis, by Application USD Million (2021-2026)
  • Table 165. Rest of South America Apheresis, by Technology USD Million (2021-2026)
  • Table 166. Rest of South America Apheresis, by Procedure USD Million (2021-2026)
  • Table 167. Asia Pacific Apheresis, by Country USD Million (2021-2026)
  • Table 168. Asia Pacific Apheresis, by Type USD Million (2021-2026)
  • Table 169. Asia Pacific Apheresis, by Application USD Million (2021-2026)
  • Table 170. Asia Pacific Apheresis, by Technology USD Million (2021-2026)
  • Table 171. Asia Pacific Apheresis, by Procedure USD Million (2021-2026)
  • Table 172. China Apheresis, by Type USD Million (2021-2026)
  • Table 173. China Apheresis, by Application USD Million (2021-2026)
  • Table 174. China Apheresis, by Technology USD Million (2021-2026)
  • Table 175. China Apheresis, by Procedure USD Million (2021-2026)
  • Table 176. Japan Apheresis, by Type USD Million (2021-2026)
  • Table 177. Japan Apheresis, by Application USD Million (2021-2026)
  • Table 178. Japan Apheresis, by Technology USD Million (2021-2026)
  • Table 179. Japan Apheresis, by Procedure USD Million (2021-2026)
  • Table 180. India Apheresis, by Type USD Million (2021-2026)
  • Table 181. India Apheresis, by Application USD Million (2021-2026)
  • Table 182. India Apheresis, by Technology USD Million (2021-2026)
  • Table 183. India Apheresis, by Procedure USD Million (2021-2026)
  • Table 184. South Korea Apheresis, by Type USD Million (2021-2026)
  • Table 185. South Korea Apheresis, by Application USD Million (2021-2026)
  • Table 186. South Korea Apheresis, by Technology USD Million (2021-2026)
  • Table 187. South Korea Apheresis, by Procedure USD Million (2021-2026)
  • Table 188. Taiwan Apheresis, by Type USD Million (2021-2026)
  • Table 189. Taiwan Apheresis, by Application USD Million (2021-2026)
  • Table 190. Taiwan Apheresis, by Technology USD Million (2021-2026)
  • Table 191. Taiwan Apheresis, by Procedure USD Million (2021-2026)
  • Table 192. Australia Apheresis, by Type USD Million (2021-2026)
  • Table 193. Australia Apheresis, by Application USD Million (2021-2026)
  • Table 194. Australia Apheresis, by Technology USD Million (2021-2026)
  • Table 195. Australia Apheresis, by Procedure USD Million (2021-2026)
  • Table 196. Rest of Asia-Pacific Apheresis, by Type USD Million (2021-2026)
  • Table 197. Rest of Asia-Pacific Apheresis, by Application USD Million (2021-2026)
  • Table 198. Rest of Asia-Pacific Apheresis, by Technology USD Million (2021-2026)
  • Table 199. Rest of Asia-Pacific Apheresis, by Procedure USD Million (2021-2026)
  • Table 200. Europe Apheresis, by Country USD Million (2021-2026)
  • Table 201. Europe Apheresis, by Type USD Million (2021-2026)
  • Table 202. Europe Apheresis, by Application USD Million (2021-2026)
  • Table 203. Europe Apheresis, by Technology USD Million (2021-2026)
  • Table 204. Europe Apheresis, by Procedure USD Million (2021-2026)
  • Table 205. Germany Apheresis, by Type USD Million (2021-2026)
  • Table 206. Germany Apheresis, by Application USD Million (2021-2026)
  • Table 207. Germany Apheresis, by Technology USD Million (2021-2026)
  • Table 208. Germany Apheresis, by Procedure USD Million (2021-2026)
  • Table 209. France Apheresis, by Type USD Million (2021-2026)
  • Table 210. France Apheresis, by Application USD Million (2021-2026)
  • Table 211. France Apheresis, by Technology USD Million (2021-2026)
  • Table 212. France Apheresis, by Procedure USD Million (2021-2026)
  • Table 213. Italy Apheresis, by Type USD Million (2021-2026)
  • Table 214. Italy Apheresis, by Application USD Million (2021-2026)
  • Table 215. Italy Apheresis, by Technology USD Million (2021-2026)
  • Table 216. Italy Apheresis, by Procedure USD Million (2021-2026)
  • Table 217. United Kingdom Apheresis, by Type USD Million (2021-2026)
  • Table 218. United Kingdom Apheresis, by Application USD Million (2021-2026)
  • Table 219. United Kingdom Apheresis, by Technology USD Million (2021-2026)
  • Table 220. United Kingdom Apheresis, by Procedure USD Million (2021-2026)
  • Table 221. Netherlands Apheresis, by Type USD Million (2021-2026)
  • Table 222. Netherlands Apheresis, by Application USD Million (2021-2026)
  • Table 223. Netherlands Apheresis, by Technology USD Million (2021-2026)
  • Table 224. Netherlands Apheresis, by Procedure USD Million (2021-2026)
  • Table 225. Rest of Europe Apheresis, by Type USD Million (2021-2026)
  • Table 226. Rest of Europe Apheresis, by Application USD Million (2021-2026)
  • Table 227. Rest of Europe Apheresis, by Technology USD Million (2021-2026)
  • Table 228. Rest of Europe Apheresis, by Procedure USD Million (2021-2026)
  • Table 229. MEA Apheresis, by Country USD Million (2021-2026)
  • Table 230. MEA Apheresis, by Type USD Million (2021-2026)
  • Table 231. MEA Apheresis, by Application USD Million (2021-2026)
  • Table 232. MEA Apheresis, by Technology USD Million (2021-2026)
  • Table 233. MEA Apheresis, by Procedure USD Million (2021-2026)
  • Table 234. Middle East Apheresis, by Type USD Million (2021-2026)
  • Table 235. Middle East Apheresis, by Application USD Million (2021-2026)
  • Table 236. Middle East Apheresis, by Technology USD Million (2021-2026)
  • Table 237. Middle East Apheresis, by Procedure USD Million (2021-2026)
  • Table 238. Africa Apheresis, by Type USD Million (2021-2026)
  • Table 239. Africa Apheresis, by Application USD Million (2021-2026)
  • Table 240. Africa Apheresis, by Technology USD Million (2021-2026)
  • Table 241. Africa Apheresis, by Procedure USD Million (2021-2026)
  • Table 242. North America Apheresis, by Country USD Million (2021-2026)
  • Table 243. North America Apheresis, by Type USD Million (2021-2026)
  • Table 244. North America Apheresis, by Application USD Million (2021-2026)
  • Table 245. North America Apheresis, by Technology USD Million (2021-2026)
  • Table 246. North America Apheresis, by Procedure USD Million (2021-2026)
  • Table 247. United States Apheresis, by Type USD Million (2021-2026)
  • Table 248. United States Apheresis, by Application USD Million (2021-2026)
  • Table 249. United States Apheresis, by Technology USD Million (2021-2026)
  • Table 250. United States Apheresis, by Procedure USD Million (2021-2026)
  • Table 251. Canada Apheresis, by Type USD Million (2021-2026)
  • Table 252. Canada Apheresis, by Application USD Million (2021-2026)
  • Table 253. Canada Apheresis, by Technology USD Million (2021-2026)
  • Table 254. Canada Apheresis, by Procedure USD Million (2021-2026)
  • Table 255. Mexico Apheresis, by Type USD Million (2021-2026)
  • Table 256. Mexico Apheresis, by Application USD Million (2021-2026)
  • Table 257. Mexico Apheresis, by Technology USD Million (2021-2026)
  • Table 258. Mexico Apheresis, by Procedure USD Million (2021-2026)
  • Table 259. Research Programs/Design for This Report
  • Table 260. Key Data Information from Secondary Sources
  • Table 261. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Apheresis: by Type USD Million (2015-2020)
  • Figure 5. Global Apheresis: by Application USD Million (2015-2020)
  • Figure 6. Global Apheresis: by Technology USD Million (2015-2020)
  • Figure 7. Global Apheresis: by Procedure USD Million (2015-2020)
  • Figure 8. South America Apheresis Share (%), by Country
  • Figure 9. Asia Pacific Apheresis Share (%), by Country
  • Figure 10. Europe Apheresis Share (%), by Country
  • Figure 11. MEA Apheresis Share (%), by Country
  • Figure 12. North America Apheresis Share (%), by Country
  • Figure 13. Global Apheresis share by Players 2020 (%)
  • Figure 14. Global Apheresis share by Players (Top 3) 2020(%)
  • Figure 15. Global Apheresis share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Terumo BCT, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Terumo BCT, Inc. (United States) Revenue: by Geography 2020
  • Figure 19. Fresenius SE & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Fresenius SE & Co. KGaA (Germany) Revenue: by Geography 2020
  • Figure 21. Haemonetics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Haemonetics Corporation (United States) Revenue: by Geography 2020
  • Figure 23. Asahi Kasei Medical Co. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Asahi Kasei Medical Co. Ltd. (Japan) Revenue: by Geography 2020
  • Figure 25. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 27. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Baxter International Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Cerus Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cerus Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Kaneka Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Kaneka Corporation (Japan) Revenue: by Geography 2020
  • Figure 33. Kawasumi Laboratories, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Kawasumi Laboratories, Inc. (Japan) Revenue: by Geography 2020
  • Figure 35. Nikkiso Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Nikkiso Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 37. Global Apheresis: by Type USD Million (2021-2026)
  • Figure 38. Global Apheresis: by Application USD Million (2021-2026)
  • Figure 39. Global Apheresis: by Technology USD Million (2021-2026)
  • Figure 40. Global Apheresis: by Procedure USD Million (2021-2026)
  • Figure 41. South America Apheresis Share (%), by Country
  • Figure 42. Asia Pacific Apheresis Share (%), by Country
  • Figure 43. Europe Apheresis Share (%), by Country
  • Figure 44. MEA Apheresis Share (%), by Country
  • Figure 45. North America Apheresis Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Terumo BCT, Inc. (United States)
  • Fresenius SE & Co. KGaA (Germany)
  • Haemonetics Corporation (United States)
  • Asahi Kasei Medical Co. Ltd. (Japan)
  • B. Braun Melsungen AG (Germany)
  • Baxter International Inc. (United States)
  • Cerus Corporation (United States)
  • Kaneka Corporation (Japan)
  • Kawasumi Laboratories, Inc. (Japan)
  • Nikkiso Co., Ltd. (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation